Latest profit margin for Medpace Holdings: 17.67% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for MEDP is 17.67% as of June 2026. That compares with 18.74% in the prior-year period — down 5.8% year over year. That is above the Healthcare sector average of 13.89%. Investors often review this figure alongside Medpace Holdings's historical trend and sector peers before judging valuation or financial health.
Over the past year, MEDP's profit margin moved from 18.74% to 17.67% — a 5.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Medpace Holdings's valuation or profitability profile.
Against Healthcare companies, MEDP currently prints 17.67% for profit margin, while the sector average sits near 13.89%. That is roughly 27.2% above the sector mean. Large gaps often invite a closer look at Medpace Holdings's growth, margins, and balance sheet.
Profit Margin shows how effectively Medpace Holdings converts resources into returns. At 17.67%, MEDP may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 18.74% in the prior-year period — down 5.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting MEDP's profit margin (17.67%), review year-over-year change from 18.74%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.